Health Technology Assessments

Health Technology Assessments (HTAs) are a comprehensive systematic review and critical analysis of available evidence for A SINGLE medical technology for which there are several published clinical trials and a substantial body of evidence. This report details an entire technology class for which there are one or more indications or patient populations in use.

Our analysts evaluate clinical trial data, along with information regarding safety issues, coverage policies from the private and public sectors, regulatory approvals, consensus statements, and an overall projection of the potential clinical efficacy and economic impact of the technology. Reports are reviewed annually up to 5 years post publication to determine if there is new literature or evidence that would impact a change in rating and warrant an updated report.

Percutaneous Pulsed Radiofrequency for Chronic Postherpetic Neuralgia

Focus of Report: The focus of this Health Technology Assessment is to evaluate the effectiveness and safety of pulsed radiofrequency (PRF) compared with alternative treatments to treat postherpetic neuralgia (PHN) in adults.

Technology Description: PRF application is a minimally invasi…

Electrical Impedance Spectroscopy With Nevisense (SciBase AB) for Diagnosis of Cutaneous Melanoma

Focus of the Report: The focus of this Health Technology Assessment is evaluation of the effectiveness and safety of electrical impedance spectroscopy (EIS) as an adjunct to conventional clinical examination alone or combined with dermoscopy for diagnosis of cutaneous melanoma in patients who have suspicious skin lesions.

Minimally Invasive Lumbar Decompression Device Kit (Vertos Medical Inc.) for Treatment of Lumbar Spinal Stenosis

Focus of the Report: The focus of this Health Technology Assessment is to evaluate the effectiveness and safety of the minimally invasive lumbar decompression (mild) procedure, an approach that uses a proprietary surgical kit (mild; Vertos Medical Inc.) to treat lumbar spinal stenosis (LSS) in adult (≥ 18 years old) patients.

Theta Burst Stimulation for Treatment-Resistant Unipolar Depression in Adults

Focus of the Report: The focus of this Health Technology Assessment (HTA) is to evaluate the effectiveness and safety of theta burst stimulation (TBS), alone and compared with repetitive transcranial magnetic stimulation (rTMS) and/or with sham TBS, for the management of treatment-resistant major depressive disorder (MDD) (unipolar treatment-…